Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cognetivity Neurosciences Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.0025 |
52 Week High | CA$0.22 |
52 Week Low | CA$0.001 |
Beta | -0.38 |
1 Month Change | 0% |
3 Month Change | -84.85% |
1 Year Change | -98.83% |
3 Year Change | -99.29% |
5 Year Change | -98.93% |
Change since IPO | -98.68% |
Recent News & Updates
Recent updates
Shareholder Returns
1UB | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -80.8% | -5.1% | -1.5% |
1Y | -98.8% | -9.0% | 0.9% |
Return vs Industry: 1UB underperformed the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: 1UB underperformed the German Market which returned -0.4% over the past year.
Price Volatility
1UB volatility | |
---|---|
1UB Average Weekly Movement | 483.3% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1UB's share price has been volatile over the past 3 months.
Volatility Over Time: 1UB's weekly volatility has increased from 259% to 483% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | Sina Habibi | cognetivity.com |
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. Fundamentals Summary
1UB fundamental statistics | |
---|---|
Market cap | €957.62k |
Earnings (TTM) | -€5.90m |
Revenue (TTM) | €67.54k |
18.9x
P/S Ratio-0.2x
P/E RatioIs 1UB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1UB income statement (TTM) | |
---|---|
Revenue | CA$98.97k |
Cost of Revenue | CA$1.36m |
Gross Profit | -CA$1.27m |
Other Expenses | CA$7.38m |
Earnings | -CA$8.64m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.092 |
Gross Margin | -1,278.71% |
Net Profit Margin | -8,732.77% |
Debt/Equity Ratio | -19.9% |
How did 1UB perform over the long term?
See historical performance and comparison